Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is held by 316 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 162,746 | 2.35% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -283,819 | -5.57% | $0.00 |
| venBio Partners LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 250,138 | 1,834.53% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -734,160 | -19.08% | $0.00 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 31 Dec, 2025 | 0 | 193,419 | 72.79% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 80,508 | 219.55% | $0.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Dec, 2025 | 0 | 172,107 | 10.31% | $0.00 |
| Man Group plc | 31 Dec, 2025 | 0 | 29,681 | 10.71% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -72,902 | -38.70% | $0.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 0 | 139,145 | 8.23% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | 27,433 | 10.09% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 8,246 | 0.50% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -205,853 | -40.92% | $0.00 |
| LSV ASSET MANAGEMENT | 31 Dec, 2025 | 0 | 62,200 | 3.90% | $0.00 |
| Pacer Advisors, Inc. | 31 Dec, 2025 | 0 | -72,595 | -20.00% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | 196,224 | 15.15% | $0.00 |
| CX Institutional | 31 Dec, 2025 | 0 | 45,376 | 19.69% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 12,323 | 0.98% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -66,600 | -5.86% | $0.00 |